| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 19.067 | 18.616 | 0 | 0 | 1.497 | 0 | 0 | 0 | - | - |
| Total Income - EUR | 19.068 | 18.616 | 3.174 | 0 | 1.997 | 0 | 0 | 0 | - | - |
| Total Expenses - EUR | 14.329 | 17.681 | 14.608 | 134 | 219 | 166 | 20 | 20 | - | - |
| Gross Profit/Loss - EUR | 4.739 | 935 | -11.434 | -134 | 1.778 | -166 | -20 | -20 | - | - |
| Net Profit/Loss - EUR | 4.166 | 563 | -11.530 | -134 | 1.718 | -166 | -20 | -20 | - | - |
| Employees | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
Check the financial reports for the company - Bioprodalex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 22.520 | 16.267 | 1.671 | 1.603 | 1.536 | 1.477 | 1.425 | 1.409 | - | - |
| Current Assets | 11.473 | 1.698 | 4.151 | 3.914 | 5.639 | 5.349 | 5.231 | 5.247 | - | - |
| Inventories | 228 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Receivables | 5.683 | 1.489 | 1.458 | 1.431 | 1.403 | 1.377 | 1.346 | 1.350 | - | - |
| Cash | 5.562 | 209 | 2.693 | 2.482 | 4.235 | 3.973 | 3.885 | 3.897 | - | - |
| Shareholders Funds | 24.916 | 17.583 | 5.756 | 5.517 | 7.128 | 6.827 | 6.655 | 6.656 | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | - | - |
| Debts | 9.076 | 382 | 66 | 0 | 47 | 0 | 0 | 0 | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2015 - 2015" | |||||||||
| CAEN Financial Year |
2015
|
|||||||||
Comments - Bioprodalex Srl